Literature DB >> 27408412

New Codanin-1 Gene Mutations in a Italian Patient with Congenital Dyserythropoietic Anemia Type I and Heterozygous Beta-Thalassemia.

Elena D'Alcamo1, V Agrigento1, L Pitrolo1, S Sclafani1, R Barone1, G Calvaruso1, V Buffa1, A Maggio1.   

Abstract

Congenital dyserythropoietic anemia type I is an autosomal recessive disorder associated with macrocytic anemia, ineffective erythropoiesis, iron overloading and characterized by abnormal chromatin ultrastructure in erythroblasts such as internuclear chromatin bridges, spongy heterochromatin and invagination of the nuclear membrane. A 58-year-old Causasian man with chronic hemolytic anemia, heterozygous for β (+) -globin IVS1, nt110 G>A mutation (causing abnormal alpha:beta globin chain ratio) showed clinical, laboratory and hematological features suggesting diagnosis of CDA1. Sequence analysis of CDA-related genes revealed compound heterozygosity for two novel mutations in the CDAN1 gene: a frameshift mutation 3367 del 4 (TTAG) in exon 25 and a missense mutation c.1811 G>T in exon 11 causing an aminoacid change from glycine to valine at codon 565 (G565V). One of the propositus' brothers showed the same gene mutations. As the CDA1 can mimic thalassemia, a frequent misdiagnosis is possible especially in countries where the prevalence of thalassemia is high. A strong clinical suspicion in patients who do not reveal a clear genetic basis for presumed thalassemia may help clinch the correct diagnosis.

Entities:  

Keywords:  CDAN1 gene; Congenital dyserythropoietic anemia; Ineffective erythropoiesis; Internuclear chromatin bridges

Year:  2016        PMID: 27408412      PMCID: PMC4925544          DOI: 10.1007/s12288-015-0633-z

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  11 in total

1.  Reliability of EMA binding test in the diagnosis of hereditary spherocytosis in Italian patients.

Authors:  Elena D'Alcamo; Veronica Agrigento; Serena Sclafani; Angela Vitrano; Liana Cuccia; Aurelio Maggio; Silverio Perrotta; Marcello Capra; Paolo Rigano
Journal:  Acta Haematol       Date:  2010-12-11       Impact factor: 2.195

2.  Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II.

Authors:  Klaus Schwarz; Achille Iolascon; Fatima Verissimo; Nikolaus S Trede; Wyatt Horsley; Wen Chen; Barry H Paw; Karl-Peter Hopfner; Karlheinz Holzmann; Roberta Russo; Maria Rosaria Esposito; Daniela Spano; Luigia De Falco; Katja Heinrich; Brigitte Joggerst; Markus T Rojewski; Silverio Perrotta; Jonas Denecke; Ulrich Pannicke; Jean Delaunay; Rainer Pepperkok; Hermann Heimpel
Journal:  Nat Genet       Date:  2009-06-28       Impact factor: 38.330

Review 3.  Dyserythropoiesis and congenital dyserythropoietic anaemias.

Authors:  S N Wickramasinghe
Journal:  Br J Haematol       Date:  1997-09       Impact factor: 6.998

4.  The diagnostic challenge of congenital dyserythropoietic anaemia: two cases of 'CDA type II'.

Authors:  Srivasavi Dukka; May-Jean King; Quentin A Hill
Journal:  J Clin Pathol       Date:  2014-01-02       Impact factor: 3.411

5.  Congenital dyserythropoietic anemia type I is caused by mutations in codanin-1.

Authors:  Orly Dgany; Nili Avidan; Jean Delaunay; Tatyana Krasnov; Lea Shalmon; Hanna Shalev; Tal Eidelitz-Markus; Joseph Kapelushnik; Daniel Cattan; Alexandre Pariente; Michel Tulliez; Aurore Crétien; Pierre-Olivier Schischmanoff; Achille Iolascon; Eithan Fibach; Ariel Koren; Jochen Rössler; Martine Le Merrer; Isaac Yaniv; Rina Zaizov; Edna Ben-Asher; Tsvyia Olender; Doron Lancet; Jacques S Beckmann; Hannah Tamary
Journal:  Am J Hum Genet       Date:  2002-11-14       Impact factor: 11.025

6.  Clinical features and studies of erythropoiesis in Israeli Bedouins with congenital dyserythropoietic anemia type I.

Authors:  H Tamary; H Shalev; D Luria; D Shaft; M Zoldan; L Shalmon; A Gruinspan; B Stark; M Chaison; E Shinar; P Resnitzky; R Zaizov
Journal:  Blood       Date:  1996-03-01       Impact factor: 22.113

7.  Congenital dyserythropoietic anemia type III (CDA III) is caused by a mutation in kinesin family member, KIF23.

Authors:  Maria Liljeholm; Andrew F Irvine; Ann-Louise Vikberg; Anna Norberg; Stacy Month; Herbert Sandström; Anders Wahlin; Masanori Mishima; Irina Golovleva
Journal:  Blood       Date:  2013-04-09       Impact factor: 22.113

8.  Codanin-1, mutated in the anaemic disease CDAI, regulates Asf1 function in S-phase histone supply.

Authors:  Katrine Ask; Zuzana Jasencakova; Patrice Menard; Yunpeng Feng; Geneviève Almouzni; Anja Groth
Journal:  EMBO J       Date:  2012-03-09       Impact factor: 11.598

9.  Codanin-1 mutations in congenital dyserythropoietic anemia type 1 affect HP1{alpha} localization in erythroblasts.

Authors:  Raffaele Renella; Nigel A Roberts; Jill M Brown; Marco De Gobbi; Louise E Bird; Tasneem Hassanali; Jacqueline A Sharpe; Jacqueline Sloane-Stanley; David J P Ferguson; Jacqueline Cordell; Veronica J Buckle; Douglas R Higgs; William G Wood
Journal:  Blood       Date:  2011-03-01       Impact factor: 22.113

Review 10.  Clinical aspects and pathogenesis of congenital dyserythropoietic anemias: from morphology to molecular approach.

Authors:  Achille Iolascon; Maria Rosaria Esposito; Roberta Russo
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.